Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Clinical Chemistry and Laboratory Medicine|March 27, 2015
Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange ProgramAlberto Falorni, Vittorio Bini, Corrado Betterle, et al.
Diabetes Care|February 25, 2021
An Age-Related Exponential Decline in the Risk of Multiple Islet Autoantibody Seroconversion During ChildhoodEzio Bonifacio, Andreas Weiß, Christiane Winkler, et al.
Diabetes Care|July 1, 2024
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Nature Medicine|August 10, 2020
A combined risk score enhances prediction of type 1 diabetes among susceptible childrenLauric A Ferrat, Kendra Vehik, Seth A Sharp, et al.
Scientific Reports|April 24, 2021
Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in SwedenLue Ping Zhao, George K Papadopoulos, Antonis K Moustakas, et al.
Genome Research|August 25, 2012
Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humansHuriya Beyan, Thomas A Down, Sreeram V Ramagopalan, et al.
Diabetologia|October 10, 2017
Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study childrenHelena Elding Larsson, Kristian F Lynch, Maria Lönnrot, et al.
Clinical Diabetes and Endocrinology|January 5, 2022
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFAMaria Månsson Martinez, Lampros Spiliopoulos, Falastin Salami, et al.
Diabetes|April 5, 2020
Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 ChildrenLue Ping Zhao, George K Papadopoulos, William W Kwok, et al.
Diabetes|December 3, 2025
Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 DiabetesLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Pageof 18